Oncology Institute (DFPH) Enterprise Value (2019 - 2026)

Oncology Institute (DFPH) has reported Enterprise Value for 8 consecutive years, with -$30.3 million the latest figure, recorded in Q1 2026.

• Enterprise Value for Q1 2026 came in at -$30.3 million, up 23.8% year-over-year; the trailing twelve-month figure through Mar 2026 was -$30.3 million (up 23.8% YoY), and the FY2025 annual result was -$33.6 million, up 32.42% from the prior year.
• Enterprise Value was -$30.3 million for Q1 2026 at Oncology Institute, up from -$33.6 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$27.7 million in Q3 2025 and troughed at -$95.5 million in Q1 2022.
• Average Enterprise Value over 5 years is -$56.5 million, with a median of -$49.7 million recorded in 2024.
• Year-over-year, Enterprise Value tumbled 685.46% in 2022 and soared 45.77% in 2024.
• Over 5 years, Enterprise Value stood at -$73.8 million in 2022, then declined by 12.26% to -$82.9 million in 2023, then soared by 40.05% to -$49.7 million in 2024, then jumped by 32.42% to -$33.6 million in 2025, then advanced by 9.79% to -$30.3 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$30.3 million in Q1 2026, -$33.6 million in Q4 2025, and -$27.7 million in Q3 2025.